Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products
Open accessThe DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Abstract
Dietary fish oil containing omega 3 highly unsaturated fatty acids has cardioprotective and anti-inflammatory effects. Prostaglandins (PGs) and thromboxanes are produced in vivo both from the omega 6 fatty acid arachidonic acid (AA) and the omega 3 fatty acid eicosapentaenoic acid (EPA). Certain beneficial effects of fish oil may result from altered PG metabolism resulting from increases in the EPA/AA ratios of precursor phospholipids. Here we report in vitro specificities of prostanoid enzymes and receptors toward EPA-derived, 3-series versus AA-derived, 2-series prostanoid substrates and products. The largest difference was seen with PG endoperoxide H synthase (PGHS)-1. Under optimal conditions purified PGHS-1 oxygenates EPA with only 10% of the efficiency of AA, and EPA significantly inhibits AA oxygenation by PGHS-1. Two- to 3-fold higher activities or potencies with 2-series versus 3-series compounds were observed with PGHS-2, PGD synthases, microsomal PGE synthase-1 and EP1, EP2, EP3, and FP receptors. Our most surprising observation was that AA oxygenation by PGHS-2 is only modestly inhibited by EPA (i.e. PGHS-2 exhibits a marked preference for AA when EPA and AA are tested together). Also unexpectedly, TxA(3) is about equipotent to TxA(2) at the TP alpha receptor. Our biochemical data predict that increasing phospholipid EPA/AA ratios in cells would dampen prostanoid signaling with the largest effects being on PGHS-1 pathways involving PGD, PGE, and PGF. Production of 2-series prostanoids from AA by PGHS-2 would be expected to decrease in proportion to the compensatory decrease in the AA content of phospholipids that would result from increased incorporation of omega 3 fatty acids such as EPA.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“EPA derived eicosanoids also display a reduced affinity for eicosanoid receptors rendering them up to 50%–80% less biologically active than AA derived eicosanoids [149].”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [149]
In the citing paper
“Conversely, eicosanoids derived from n-3 PUFAs are considered to be less potent, reducing the intensity and duration of the inflammatory responses by immune cells [62].”
From Potential Roles of n-3 PUFAs during Skeletal Muscle Growth and Regeneration (2018) · cites this paper as [62]
Citations
Cites
Cyclooxygenases: Structural, cellular, and molecular biology
Smith, W. L., DeWitt, D. L., & Garavito, R. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.145 · Cited by 2,925
Self-citationThe Inverse Relation between Fish Consumption and 20-Year Mortality from Coronary Heart Disease
Kromhout, D., Bosschieter, E. B., & Coulander, C. D. L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505093121901 · Cited by 2,177
Seibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J., Perkins, W., Lee, L., & Isakson, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12013 · Cited by 1,551
Diversity of group types, regulation, and function of phospholipase A2.
Dennis, E. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36794-7 · Cited by 1,436
Biochemistry of Lipids, Lipoproteins and Membranes
(2021) · Elsevier eBooks · doi:10.1016/c2020-0-00089-7 · Cited by 1,400
Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.
Masferrer, J. L., Zweifel, B. S., Manning, P. T., Hauser, S. D., Leahy, K. M., Smith, W. G., Isakson, P. C., & Seibert, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3228 · Cited by 1,310
Self-citationSugimoto, Y., & Narumiya, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r600038200 · Cited by 1,196
Langenbach, R., Morham, S. G., Tiano, H. F., Loftin, C. D., Ghanayem, B. I., Chulada, P. C., Mahler, J. F., Lee, C. A., Goulding, E. H., Kluckman, K. D., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90126-4 · Cited by 1,123
Hirai, H., Tanaka, K., Yoshie, O., Ogawa, K., Kenmotsu, K., Takamori, Y., Ichimasa, M., Sugamura, K., Nakamura, M., Takano, S., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.255 · Cited by 1,099
Resolution of in flammation: state of the art, definitions and terms
Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A. J., Perretti, M., Rossi, A. G., & Wallace, J. L. (2007) · The FASEB Journal · doi:10.1096/fj.06-7227rev · Cited by 1,045
Research works printed but not linked: 4
- Kris-Etherton, 2003, Arterioscler. Thromb. Vasc. Biol., 23, 20
- Fisher, 1989, Mol. Pharmacol., 35, 195
- Lands, 1973, Adv. Biosci., 9, 15
- Yu, 2005, J. Clin. Invest., 115, 986, 10.1172/JCI23683 · doi:10.1172/jci23683 · Paper page
Cited by
Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance
Calder, P. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.010 · Cited by 1,717
Eicosanoid storm in infection and inflammation
Dennis, E. A., & Norris, P. C. (2015) · Nature Reviews Immunology · doi:10.1038/nri3859 · Cited by 1,517
Omega-3 fatty acids and inflammatory processes: from molecules to man
Calder, P. C. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160474 · Cited by 1,456
“One reason for this reduced biological potency is that eicosanoid receptors typically have a lower affinity for the EPA-derived mediator than for the ARA-derived one [18].”
Omega‐3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?
Calder, P. C. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04374.x · Cited by 1,347
Omega-6 fatty acids and inflammation
Innes, J. K., & Calder, P. C. (2018) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2018.03.004 · Cited by 929
“The extent of this competition depends upon the concentration of the competing compounds and the relative affinities of the enzymes and receptors for the various substrates and ligands [58].”
BackgroundMechanisms of Action of (n-3) Fatty Acids,
Calder, P. C. (2012) · The Journal of Nutrition · doi:10.3945/jn.111.155259 · Cited by 871
“(78) reported that PG D3 interacted more strongly with the DP1 receptor than did PG D2.”
BackgroundAdvances in Our Understanding of Oxylipins Derived from Dietary PUFAs
Gabbs, M., Leng, S., Devassy, J. G., Monirujjaman, M., & Aukema, H. M. (2015) · Advances in Nutrition · doi:10.3945/an.114.007732 · Cited by 798
“PGI3 and PGI2 also have similar vasodilatory and antiaggregatory effects on platelets (286) and thromboxane A2 and thromboxane A3 have a similar ability to elevate plasma catecholamines in rats or to activate the thromboxane receptor (81, 283, 286, 384).”
BackgroundInfluentialArachidonic-acid-derived eicosanoids: roles in biology and immunopathology
Harizi, H., Corcuff, J.-B., & Gualde, N. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.08.005 · Cited by 636
n–3 Fatty Acids in Cardiovascular Disease
De Caterina, R. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1008153 · Cited by 568
Nutrition, immunity and COVID-19
Calder, P. C. (2020) · BMJ Nutrition, Prevention & Health · doi:10.1136/bmjnph-2020-000085 · Cited by 426
Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology
Buczynski, M. W., Dumlao, D. S., & Dennis, E. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900004-jlr200 · Cited by 530
Enzymes of the Cyclooxygenase Pathways of Prostanoid Biosynthesis
Smith, W. L., Urade, Y., & Jakobsson, P.-J. (2011) · Chemical Reviews · doi:10.1021/cr2002992 · Cited by 503
Self-citationVery long-chain n -3 fatty acids and human health: fact, fiction and the future
Calder, P. C. (2018) · Proceedings of the Nutrition Society · doi:10.1017/s0029665117003950 · Cited by 419
“P ro ce ed in gs o f th e N u tr it io n So ci et y aggregator than thromboxane A2 produced from ARA(76).”
BackgroundInfluential(n-3) Fatty Acids and Cardiovascular Health: Are Effects of EPA and DHA Shared or Complementary?
Mozaffarian, D., & Wu, J. H. Y. (2012) · The Journal of Nutrition · doi:10.3945/jn.111.149633 · Cited by 368
n -3 Fatty acids, inflammation and immunity: new mechanisms to explain old actions
Calder, P. C. (2013) · Proceedings of the Nutrition Society · doi:10.1017/s0029665113001031 · Cited by 364
“One reason for this reduced biological potency is that eicosanoid receptors typically have a much lower affinity for the EPA-derived mediator than for the arachidonic acid-derived one((63)).”
Multi-targeted therapy of cancer by omega-3 fatty acids
Berquin, I. M., Edwards, I. J., & Chen, Y. Q. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.044 · Cited by 364
Arachidonic Acid-metabolizing Cytochrome P450 Enzymes Are Targets of ω-3 Fatty Acids*
Arnold, C., Markovic, M., Blossey, K., Wallukat, G., Fischer, R., Dechend, R., Konkel, A., von Schacky, C., Luft, F. C., Muller, D. N., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.118406 · Cited by 352
Calder, P. C. (2020) · Essays in Biochemistry · doi:10.1042/ebc20190083 · Cited by 321
Very long chain omega‐3 (n‐3) fatty acids and human health
Calder, P. C. (2014) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201400025 · Cited by 265
“Frequently, though not always, the EPA‐derived mediator has weaker biological activity than the arachidonic acid‐derived mediator [63].”
Calder, P. C. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100710 · Cited by 255
“Usually the EPA-derived mediators are less biologically active than those produced from arachidonic acid [25, 32] or they may even antagonise the action of those produced from arachidonic acid [33].”
BackgroundOrlando, B. J., & Malkowski, M. G. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.725713 · Cited by 247
Omega-3 Fatty Acids for Cardioprotection
Lee, J. H., O'Keefe, J. H., Lavie, C. J., Marchioli, R., & Harris, W. S. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.3.324 · Cited by 249
Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis
West, N. J., Clark, S. K., Phillips, R. K. S., Hutchinson, J. M., Leicester, R. J., Belluzzi, A., & Hull, M. A. (2010) · Gut · doi:10.1136/gut.2009.200642 · Cited by 244
“On the one hand, EPA can act as an alternative (although poorly efficient) substrate for COX-2, rather than its usual ω-6 PUFA substrate AA,”
BackgroundOmega-3 fatty acid supplementation and cardiovascular disease
Jump, D. B., Depner, C. M., & Tripathy, S. (2012) · Journal of Lipid Research · doi:10.1194/jlr.r027904 · Cited by 239
Fatty Acid–Regulated Transcription Factors in the Liver
Jump, D. B., Tripathy, S., & Depner, C. M. (2013) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071812-161139 · Cited by 228
Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids
Konkel, A., & Schunck, W.-H. (2011) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.09.009 · Cited by 227
Ouellet, M., Emond, V., Chen, C. T., Julien, C., Bourasset, F., Oddo, S., LaFerla, F., Bazinet, R. P., & Calon, F. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.04.018 · Cited by 227
“, 2007) or over 50 mM according to other authors (Wada et al., 2007).”
Long-chain fatty acids and inflammation
Calder, P. C. (2012) · Proceedings of The Nutrition Society · doi:10.1017/s0029665112000067 · Cited by 222
“EPA is also a substrate for the COX and lipoxygenase, but the mediators produced have a different structure from the arachidonic acid-derived mediators, and this often influences their potency((57)).”
BackgroundMcGlory, C., Calder, P. C., & Nunes, E. A. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00144 · Cited by 218
Fischer, R., Konkel, A., Mehling, H., Blossey, K., Gapelyuk, A., Wessel, N., von Schacky, C., Dechend, R., Muller, D. N., Rothe, M., et al. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m047357 · Cited by 215
Human Biochemistry of the Isoprostane Pathway
Milne, G. L., Yin, H., & Morrow, J. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r700047200 · Cited by 208
Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1
Rimon, G., Sidhu, R. S., Lauver, D. A., Lee, J. Y., Sharma, N. P., Yuan, C., Frieler, R. A., Trievel, R. C., Lucchesi, B. R., & Smith, W. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909765106 · Cited by 205
Self-citationRouzer, C. A., & Marnett, L. J. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00215 · Cited by 199
Omega-3 Fatty Acids and Skeletal Muscle Health
Jeromson, S., Gallagher, I., Galloway, S., & Hamilton, D. (2015) · Marine Drugs · doi:10.3390/md13116977 · Cited by 203
“50%–80% less biologically active than AA derived eicosanoids [149].”
BackgroundReview of Eukaryote Cellular Membrane Lipid Composition, with Special Attention to the Fatty Acids
Ali, O., & Szabó, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115693 · Cited by 191
NSAIDs and Cardiovascular Diseases: Role of Reactive Oxygen Species
Ghosh, R., Alajbegovic, A., & Gomes, A. V. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/536962 · Cited by 195
“While the EPA of fish oils inhibited COX-1 more than COX-2 [168], DCHA was shown to be an effective inhibitor of arachidonic acid induced prostaglandin biosynthesis [169].”
BackgroundSchunck, W.-H., Konkel, A., Fischer, R., & Weylandt, K.-H. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.016 · Cited by 196
“The cytosolic calcium-dependent cPLA2 releases AA and EPA with almost equal efficiencies, but is largely inactive in liberating DHA (Wada et al., 2007).”
BackgroundOmega-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signaling
Norris, P. C., & Dennis, E. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200189109 · Cited by 193
“WB WB Co nt ro l Co nt ro l A A EP A D H A EP A A A D H A Rep. 1 Rep. 2 8 Hr KLA COX-2 GAPDH6 ce lls ) 0 30 60 90 120 0 4 8 12 16 20 24 PGE2 Ei co sa no id ( pm ol /1 0 0 10 20 30 40 50 0 4 8 12 16 20 24 HETE11- 0 1 2 3 4 0 4 8 12 16 20 24 PGD3 Time (Hr) 0 0.2 0.4 0.6 0.8 1 0 4 8 12 16 20 24 2Dihomo PGD Control AA EPA…”
BackgroundInfluentialWang, Y., Armando, A. M., Quehenberger, O., Yan, C., & Dennis, E. A. (2014) · Journal of Chromatography A · doi:10.1016/j.chroma.2014.07.006 · Cited by 185
Devassy, J. G., Leng, S., Gabbs, M., Monirujjaman, M., & Aukema, H. M. (2016) · Advances in Nutrition · doi:10.3945/an.116.012187 · Cited by 183
The role of transcription factor Nrf2 in skin cells metabolism
Gęgotek, A., & Skrzydlewska, E. (2015) · Archives of Dermatological Research · doi:10.1007/s00403-015-1554-2 · Cited by 180
“nases (COX) that oxidizes arachidonic acid to PGH2 that is further metabolized by specific PG isomerases to PGE2, PGD2, PGF2a, TXA2, and prostacyclin I2 [118].”
BackgroundCytochrome P450–dependent metabolism of ω-6 and ω-3 long-chain polyunsaturated fatty acids
Arnold, C., Konkel, A., Fischer, R., & Schunck, W.-H. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70311-x · Cited by 174
Structural Basis of Fatty Acid Substrate Binding to Cyclooxygenase-2
Vecchio, A. J., Simmons, D. M., & Malkowski, M. G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.119867 · Cited by 164
Santos, H. O., Price, J. C., & Bueno, A. A. (2020) · Nutrients · doi:10.3390/nu12103159 · Cited by 154
“Experimental evidence alludes to a slower enzymatic metabolism of n3-PUFAs in relation to n6-PUFAs [30].”
Backgroundn-3 PUFA and inflammation: from membrane to nucleus and from bench to bedside
Calder, P. C. (2020) · Proceedings of the Nutrition Society · doi:10.1017/s0029665120007077 · Cited by 151
“One reason for this reduced biological potency is that eicosanoid receptors typically have a lower affinity for the EPA-derived mediator as described by Wada et al.((57)).”
Historical perspectives on the impact of n-3 and n-6 nutrients on health
Lands, B. (2014) · Progress in Lipid Research · doi:10.1016/j.plipres.2014.04.002 · Cited by 142
“A unique, detailed study of enzymes and receptors showedmany (but not all) n-3 analogs are active, but less potent than the corresponding n-6 mediators in promoting receptor-mediated processes [24].”
BackgroundA critique of paradoxes in current advice on dietary lipids
Lands, B. (2008) · Progress in Lipid Research · doi:10.1016/j.plipres.2007.12.001 · Cited by 150
“Surprisingly, one PGD receptor, DP1, appeared to be the only gene product that acts more strongly with the n!3 than the n!6 homolog [154].”
BackgroundTherapies targeting lipid peroxidation in traumatic brain injury
Anthonymuthu, T. S., Kenny, E. M., & Bayır, H. (2016) · Brain Research · doi:10.1016/j.brainres.2016.02.006 · Cited by 137
The Content of Favorable and Unfavorable Polyunsaturated Fatty Acids Found in Commonly Eaten Fish
Weaver, K. L., Ivester, P., Chilton, J. A., Wilson, M. D., Pandey, P., & Chilton, F. H. (2008) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2008.04.023 · Cited by 134
Can Early Omega-3 Fatty Acid Exposure Reduce Risk of Childhood Allergic Disease?
Miles, E., & Calder, P. (2017) · Nutrients · doi:10.3390/nu9070784 · Cited by 133
“In addition to the reduced production of eicosanoids from AA, EPA is a 181 substrate for COX and LOX enzymes, producing eicosanoids with a slightly different structure to 182 those formed from AA, and the EPA‐derived eicosanoids are frequently much less potent than the 183 AA‐derived ones [17,47,48].”
BackgroundRole of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues
Sherratt, S. C. R., Libby, P., Budoff, M. J., Bhatt, D. L., & Mason, R. P. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01075-x · Cited by 129
Yuan, C., Sidhu, R. S., Kuklev, D. V., Kado, Y., Wada, M., Song, I., & Smith, W. L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808634200 · Cited by 130
Self-citationProinflammatory and Immunoregulatory Roles of Eicosanoids in T Cells
Lone, A. M., & Taskén, K. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00130 · Cited by 148
“While some eicosanoids are produced from eicosapentaenoic acid (EPA, 20:5 ω-3) (Wada et al., 2007) or dihomo-γ-linolenic acid (DGLA, 20:3 ω-6), the majority arise from processing of arachidonic acid (AA, 20:4 ω-6) (Harizi et al., 2008).”
BackgroundInflammation at the Molecular Interface of Atherogenesis
Lamon, B. D., & Hajjar, D. P. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080442 · Cited by 143
“These molecules are precursors to eicosanoids that reduce inflammation and serve to mitigate the synthesis of proinflammatory eicosanoids from the metabolism of arachidonic acid and other -6 fatty acids.(61) Fish oil is a prominent source of -3 fatty acids and has been demonstrated to exert a suppressive effect on the…”
BackgroundMaki, K. C., Eren, F., Cassens, M. E., Dicklin, M. R., & Davidson, M. H. (2018) · Advances in Nutrition · doi:10.1093/advances/nmy038 · Cited by 142
CYP-eicosanoids—A new link between omega-3 fatty acids and cardiac disease?
Westphal, C., Konkel, A., & Schunck, W. (2011) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2011.09.001 · Cited by 139
Lipid metabolism and endometrial receptivity
Yang, T., Zhao, J., Liu, F., & Li, Y. (2022) · Human Reproduction Update · doi:10.1093/humupd/dmac026 · Cited by 150
Impact of omega-3 fatty acids in Parkinson's disease
Bousquet, M., Calon, F., & Cicchetti, F. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.03.001 · Cited by 135
Murff, H. J., Shu, X., Li, H., Yang, G., Wu, X., Cai, H., Wen, W., Gao, Y.-T., & Zheng, W. (2010) · International Journal of Cancer · doi:10.1002/ijc.25703 · Cited by 134
“Alternatively, marinederived n-3 PUFAs such as eicosapentanoic acid (EPA) and docosahexanoic acid (DHA) are the precursor molecules to eicosanoids that are less inflammatory when compared to ARAderived prostanoids.(8,9) As such the substitution of n-3 PUFA for n-6 PUFAs within the diet could have a chemopreventive eff…”
BackgroundProstaglandins and bone metabolism
Choudhary, S., & Pilbeam, C. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00051-8 · Cited by 118
Two Distinct Pathways for Cyclooxygenase-2 Protein Degradation
Mbonye, U. R., Yuan, C., Harris, C. E., Sidhu, R. S., Song, I., Arakawa, T., & Smith, W. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710137200 · Cited by 128
Self-citationNutritionally essential fatty acids and biologically indispensable cyclooxygenases
Smith, W. L. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.09.013 · Cited by 132
Self-citationDietary modulation of oxylipins in cardiovascular disease and aging
Caligiuri, S. P. B., Parikh, M., Stamenković, A., Pierce, G. N., & Aukema, H. M. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00201.2017 · Cited by 127
Bioactive products formed in humans from fish oils
Skarke, C., Alamuddin, N., Lawson, J. A., Li, X., Ferguson, J. F., Reilly, M. P., & FitzGerald, G. A. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m060392 · Cited by 109
Self-citationVrablik, T. L., & Watts, J. L. (2013) · Molecular Reproduction and Development · doi:10.1002/mrd.22167 · Cited by 120
“The COX1 enzyme oxygenates the omega-3 PUFA EPA at 10% of the efficiency observed with the omega-6 PUFA substrate AA (Wada et al., 2007).”
BackgroundMarine OMEGA-3 fatty acids in the prevention of cardiovascular disease
Mori, T. A. (2017) · Fitoterapia · doi:10.1016/j.fitote.2017.09.015 · Cited by 124
Prostaglandin H synthase: Resolved and unresolved mechanistic issues
Tsai, A., & Kulmacz, R. J. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.08.019 · Cited by 106
Potential Roles of n-3 PUFAs during Skeletal Muscle Growth and Regeneration
Tachtsis, B., Camera, D., & Lacham-Kaplan, O. (2018) · Nutrients · doi:10.3390/nu10030309 · Cited by 104
“Conversely, eicosanoids derived from n-3 PUFAs are considered to be less potent, reducing the intensity and duration of the inflammatory responses by immune cells [62].”
BackgroundDistinguishing Health Benefits of Eicosapentaenoic and Docosahexaenoic Acids
Russell, F. D., & Bürgin-Maunder, C. (2012) · Marine Drugs · doi:10.3390/md10112535 · Cited by 122
de Sire, R., Rizzatti, G., Ingravalle, F., Pizzoferrato, M., Petito, V., Lopetuso, L. R., Graziani, C., Alessandro de, S. I. R. E., Mentella, M. C., Mele, M. C., et al. (2018) · Minerva Gastroenterologica e Dietologica · doi:10.23736/s1121-421x.18.02511-4 · Cited by 101
The expansive role of oxylipins on platelet biology
Yeung, J., Hawley, M., & Holinstat, M. A. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1542-4 · Cited by 104
“PGE3 had been suggested to be a partial agonist of the EP receptors in human kidney cells with varying degree of affinity potencies [29], inducing secondary messenger actions.”
BackgroundNandivada, P., Fell, G. L., Gura, K. M., & Puder, M. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.103986 · Cited by 96
“One of the principal metabolites of v-3 fatty acid metabolism, EPA, competes with AA as a substrate for the cyclooxygenase enzyme, and thereby inhibits the production of prothrombotic factors from AA (36).”
BackgroundWachira, J. K., Larson, M. K., & Harris, W. S. (2014) · British Journal of Nutrition · doi:10.1017/s000711451300425x · Cited by 91
“The closing words of Wada et al. (65) are relevant in this regard: ‘All of these values (summarized above) were obtained under optimal in vitro conditions.”
InfluentialConsequences of Essential Fatty Acids
Lands, B. (2012) · Nutrients · doi:10.3390/nu4091338 · Cited by 99
“COX-1 reacts much more rapidly with the n-6 arachidonate to form PGH2 than with the n-3 eicosapentaenoate to form PGH3 [15].”
BackgroundResultInfluentialPolyunsaturated fatty acids: any role in rheumatoid arthritis?
Navarini, L., Afeltra, A., Afflitto, G. G., & Margiotta, D. P. E. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0586-3 · Cited by 103
“For example, PGE3 seems to be 50–80 times less potent than PGE2 towards the EP1, EP2, EP3 and EP4 receptors [18].”
BackgroundLi, X., Yu, Y., & Funk, C. D. (2013) · The FASEB Journal · doi:10.1096/fj.13-235333 · Cited by 97
“There are certainly alternative pathways to explain some of DHA’s potential actions, including substrate competition with AA (48) or generation of DHA metabolites.”
BackgroundEffects of Broodstock Diet on Eggs and Larvae
Fernández-Palacios, H., Norberg, B., Izquierdo, M. S., & Hamre, K. (2011) · Wiley eBooks · doi:10.1002/9780470959862.ch5 · Cited by 106
Cyclooxygenases and the cardiovascular system
Mitchell, J. A., Kirkby, N. S., Ahmetaj‐Shala, B., Armstrong, P. C. J., Crescente, M., Ferreira, P., Pires, M. E. L., Vaja, R., & Warner, T. D. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107624 · Cited by 94
Margina, D. M., Ungurianu, A., Purdel, C. N., Nițulescu, G. M., Tsoukalas, D., Sarandi, E., Thanasoula, M., Burykina, T. I., Tekos, F., Djordjević, A. B., et al. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111558 · Cited by 94
“11 the effect of the ARA-derived PGD2, due to a stronger interaction with the DP1 receptor compared to PGD2 (Wada et al., 2007).”
Hawcroft, G., Loadman, P. M., Belluzzi, A., & Hull, M. A. (2010) · Neoplasia · doi:10.1593/neo.10388 · Cited by 89
Gladine, C., Ostermann, A. I., Newman, J. W. I., & Schebb, N. H. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.05.012 · Cited by 95
Kwon, Y. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900824 · Cited by 84
Nonpharmacologic Treatment of Dyslipidemia
Houston, M. C., Fazio, S., Chilton, F. H., Wise, D. E., Jones, K. B., Barringer, T. A., & Bramlet, D. A. (2009) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.02.002 · Cited by 110
Pearl, D. S., Masoodi, M., Eiden, M., Brümmer, J., Gullick, D. R., McKeever, T. M., Whittaker, M. A., Nitch‐Smith, H., Brown, J. F., Shute, J. K., et al. (2013) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2013.03.013 · Cited by 90
“2 15 (22) 3 11 (16) 4 10 (14) Smoking history (n (%)) 5 (7)”
Murray, M. T., Hraiki, A., Bebawy, M., Pazderka, C., & Rawling, T. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.01.008 · Cited by 101
“…otherω−3 and ω−6 PUFA as substrates, but with varying efficiencies (Vecchio et al., 2010); such reactions also generate products that are structurally similar to the PGs derived from arachidonic acid, but that have quite distinct biological activities (Wada et al., 2007; Siddiqui et al., 2008).”
BackgroundBrooks, J. D., Milne, G. L., Yin, H., Sanchez, S. C., Porter, N. A., & Morrow, J. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800122200 · Cited by 82
Neurofurans, Novel Indices of Oxidant Stress Derived from Docosahexaenoic Acid
Song, W., Lawson, J. A., Reilly, D. F., Rokach, J., Chang, C.-T., Giasson, B. I., & FitzGerald, G. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706124200 · Cited by 86
Self-citationPartial rescue of Rett syndrome by ω-3 polyunsaturated fatty acids (PUFAs) oil
Felice, C. D., Signorini, C., Durand, T., Ciccoli, L., Leoncini, S., D’Esposito, M., Filosa, S., Oger, C., Guy, A., Bultel‐Poncé, V., et al. (2012) · Genes & Nutrition · doi:10.1007/s12263-012-0285-7 · Cited by 90
Omega-3 Fatty Acids and Cardiovascular Disease: New Developments and Applications
Harris, W. S., Dayspring, T. D., & Moran, T. J. (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.11.2717 · Cited by 79
Surette, M. E. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200706 · Cited by 84
Stability and analysis of eicosanoids and docosanoids in tissue culture media
Maddipati, K. R., & Zhou, S. (2011) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2011.01.003 · Cited by 80
Prostaglandin E3 metabolism and cancer
Yang, P., Jiang, Y., & Fischer, S. M. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.03.010 · Cited by 84
“studied the receptor binding specificities of PGE2/PGE3 to EP and PGF2α/ PGF3α to FP receptors using cell membrane from human kidney cells [22].”
BackgroundMethodInfluentialSmith, W. L., & Malkowski, M. G. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.tm118.006295 · Cited by 78
Self-citationControl of adipogenesis by oxylipins, GPCRs and PPARs
Barquissau, V., Ghandour, R. A., Ailhaud, G. P., Klingenspor, M., Langin, D., Amri, E., & Pisani, D. F. (2016) · Biochimie · doi:10.1016/j.biochi.2016.12.012 · Cited by 83
Westphal, C., Konkel, A., & Schunck, W. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-16009-2_6 · Cited by 83
Mori, T. A. (2014) · Food & Function · doi:10.1039/c4fo00393d · Cited by 91
Tomaszewski, N., He, X., Solomon, V., Lee, M., Mack, W. J., Quinn, J. F., Braskie, M. N., & Yassine, H. N. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-191017 · Cited by 76
“Cellular studies demonstrate that DHA, EPA, and AA play key roles in several metabolic processes relevant to AD pathogenesis and neuroinflammation [1, 36].”
Winnik, S. H., Lohmann, C., Richter, E., Schäfer, N., Song, W., Leiber, F., Mocharla, P., Hofmann, J., Klingenberg, R., Borén, J., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq501 · Cited by 81
“These findings may be of mechanistic relevance as some 3-series analogues such as TxA3 are less potent ligands at prostanoid receptors than the corresponding AA-derived product.(45) Given that genetic deletion and pharmacological inhibition of the Tx receptor (TP) decrease atherogenesis in mice and that iPs may act as…”
BackgroundSelf-citationRen, J., Dong, H., Han, Y., Yang, L., Zhang, A., Sun, H. J., Li, Y., Yan, G., & Wang, X. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153266 · Cited by 75
Yeung, J., Tourdot, B. E., Adili, R., Green, A. R., Freedman, C. J., Fernandez‐Perez, P., Yu, J. X., Holman, T. R., & Holinstat, M. A. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308050 · Cited by 83
“PUFAs are primarily thought to exert their regulatory effects on platelet function through their conversion into bioactive lipids (oxylipins) by oxygenases.(7) In platelets, DGLA can be oxidized by cyclooxygenase-1 (COX-1) or platelet 12-lipoxygenase (12-LOX)(8) after its release from the phospholipid bilayer predomin…”
Background
Metadata
- Authors
- Wada, M., DeLong, C. J., Hong, Y. H., Rieke, C. J., Song, I., Sidhu, R. S., Yuan, C., Warnock, M., Schmaier, A. H., Yokoyama, C., Smyth, E. M., Wilson, S. J., FitzGerald, G. A., Garavito, R. M., Sui, D. X., Regan, J. W., & Smith, W. L.
- Affiliations
- University of Michigan (US)
- Tokyo Medical and Dental University (JP)
- University of Pennsylvania (US)
- Michigan State University (US)
- University of Arizona (US)
- Corresponding author
- Smith, William L.
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-08
- Volume
- 282
- Issue
- 31
- Pages
- 22254-22266
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2047319374
- Cited by
- 400
- References
- 121
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 14 · 2023: 13 · 2022: 14 · 2021: 21 · 2020: 25 · 2019: 22 · 2018: 24 · 2017: 26 · 2016: 24 · 2015: 26 · 2014: 32 · 2013: 28 · 2012: 22
- FWCI
- 21.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4800 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1f32hl075993-01a1)
- National Heart, Lung, and Blood Institute (HL075993, HL56773, R01HL056773)
- National Institute of General Medical Sciences (GM-68848, R01GM068848)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- prostaglandins, eicosapentaenoic acid, arachidonic acid, omega-3 fatty acids, fish oil, prostanoid metabolism, cyclooxygenase-1, cyclooxygenase-2, prostaglandin D synthase, prostaglandin E receptors, prostaglandin F receptor, substrate specificity, EPA/AA ratio, phospholipid fatty acid composition
- MeSH terms
- Animals, Anti-Inflammatory Agents, Cell Line, Fish Oils, Humans, Inositol Phosphates, Phospholipids, Prostaglandins, Thromboxane A2, Thromboxanes, Eicosapentaenoic Acid, Signal Transduction, Arachidonic Acid, Mice, Platelet-Rich Plasma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.